Serum hyaluronic acid concentration in Fontan circulation: Correlation with hepatic function and portal vein hemodynamics

Pediatric Cardiology

Volumn 35, Issue 4, 2014, Pages 608-615

  Hayashi, Taiyu ^a   Inuzuka, Ryo ^a   Shindo, Takahiro ^a   Hirata, Yoichiro ^a   Shimizu, Nobutaka ^a   Oka, Akira ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fontan procedure; Hyaluronic acid; Liver fibrosis; Portal vein

Indexed keywords

HYALURONIC ACID;

ARTICLE; BLOOD LEVEL; CARBOHYDRATE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; EXPIRATORY FLOW RATE; FEMALE; FONTAN PROCEDURE; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRESCHOOL CHILD; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

ADOLESCENT; CARDIAC CATHETERIZATION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; HYALURONIC ACID; INFANT; LIVER CIRRHOSIS; MALE; PORTAL VEIN; POSTOPERATIVE PERIOD; PROGNOSIS; REGIONAL BLOOD FLOW; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, PULSED; YOUNG ADULT;

EID: 84897085658     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-013-0827-9     Document Type: Article

References (30)

1. Aboulhosn J, Williams R, Shivkumar K, Barkowski R, Plunkett M, Miner P (2010) Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion. Congenit Heart Dis 5:430-434
2. Amitrano L, Guardascione MA, Brancaccio V, Balzano A (2002) Coagulation disorders in liver disease. Semin Liver Dis 22:83-96 (Pubitemid 34225974)
3. Baek JS, Bae EJ, Ko JS, Kim GB, Kwon BS, Lee SY et al (2010) Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 96:1750-1755
4. Bulut OP, Romero R, Mahle WT, McConnell M, Braithwaite K, Shehata BM et al (2013) Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr 163:201-206
5. El-Shabrawi MH, Zein El Abedin MY, Omar N, Kamal NM, Elmakarem SA et al (2012) Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with beta-thalassaemia major. Arab J Gastroenterol 13:45-48
6. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E et al (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36:986-992
7. Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C, Schwarz P, Herrmann E (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosismarkers. J Thorac Cardiovasc Surg 135:560-567 (Pubitemid 351329330)
8. Furukawa T, Akimoto K, Ohtsuki M, Sato K, Suzuki M, Takahashi K et al (2011) Non-invasive assessment of liver fibrosis in patients after the Fontan operation. Pediatr Int 53:980-984
9. George J, Tsutsumi M, Takase S (2004) Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol 36:307-319 (Pubitemid 37487765)
10. Gewillig M (2005) The Fontan circulation. Heart 91:839-846
11. Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348-1352 (Pubitemid 40804853)
12. Hartley JL, Brown RM, Tybulewicz A, Hayes P, Wilson DC, Gillett P et al (2006) Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. J Pediatr Gastroenterol Nutr 43:217-221 (Pubitemid 44180508)
13. Hsia TY, Khambadkone S, Redington AN, Migliavacca F, Deanfield JE, de Leval MR (2000) Effects of respiration and gravity on infradiaphragmatic venous flow in normal and Fontan patients. Circulation 102(Suppl 3):III148-III153
14. Hsia TY, Khambadkone S, Deanfield JE, Taylor JF, Migliavacca F, De Leval MR (2001) Subdiaphragmatic venous hemodynamics in the Fontan circulation. J Thorac Cardiovasc Surg 121:436-447 (Pubitemid 32230211)
15. Hsia TY, Khambadkone S, Redington AN, de Leval MR (2001) Effect of fenestration on the sub-diaphragmatic venous hemodynamics in the total-cavopulmonary connection. Eur J Cardiothorac Surg 19:785-792 (Pubitemid 32515233)
16. Kaulitz R, Haber P, Sturm E, Schäfer J, Hofbeck M (2013) Serial evaluation of hepatic function profile after Fontan operation. Herz. doi:10.1007/s00059-013-3811-5
17. Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H et al (2007) Hepatic changes in the failing Fontan circulation. Heart 93:579-584 (Pubitemid 46707109)
18. Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I et al (2011) Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Acta Biochim Pol 58:563-566
19. Moreno AH, Burchell AR (1982) Respiratory regulation of splanchnic and systemic venous return in normal subjects and in patients with hepatic cirrhosis. Surg Gynecol Obstet 154:257-267 (Pubitemid 12173450)
20. Oka T, Kato R, Fumino S, Toiyama K, Yamagishi M, Itoi T (2013) Noninvasive estimation of central venous pressure after Fontan procedure using biochemical markers and abdominal echography. J Thorac Cardiovasc Surg 146:153-157
21. Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K (2012) The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 33:1001-1012
22. Schwartz MC, Sullivan LM, Glatz AC, Rand E, Russo P, Goldberg DJ et al (2013) Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol 34:135-142
23. Shah H, Kuehl K, Sherker AH (2010) Liver disease after the Fontan procedure: what the hepatologist needs to know. J Clin Gastroenterol 44:428-431
24. Sugano S, Yamamoto K, Sasao K, Watanabe M (1999) Portal venous blood flow while breath-holding after inspiration or expiration and during normal respiration in controls and cirrhotics. J Gastroenterol 34:613-618 (Pubitemid 29500326)
25. Tchelepi H, Ralls PW, Radin R, Grant E (2002) Sonography of diffuse liver disease. J Ultrasound Med 21:1023-1032 (Pubitemid 34988610)
26. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V et al (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 46:32-36 (Pubitemid 47171918)
27. Valva P, Casciato P, Diaz Carrasco JM, Gadano A, Galdame O, Galoppo MC (2011) The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One 6:e23218
28. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518-526 (Pubitemid 36919874)
29. Wallihan DB, Podberesky DJ (2013) Hepatic pathology after Fontan palliation: spectrum of imaging findings. Pediatr Radiol 43:330-338
30. Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL (2003) Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int 2:69-72